Sudeep Pharma
BSE 544619
3 stories, newest first.
- Sudeep Pharma to hold earnings call with analysts on 29 October 2026 at 12:00 noon to discuss Q2 & H1FY27 results
- Board Meeting on 28 October 2026 to Approve Unaudited Q2 and H1 Results
- MD of wholly owned US subsidiary ceases to be Senior Management Personnel w.e.f. 2nd October 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.